17.12.2019 – 14:24
App-based ECG CardioSecur Now Available in South America
A cooperation between Bambuslife and ANTEL, Uruguay's largest telecommunications provider, brings the mobile App-based ECG CardioSecur to Uruguay and 20 more countries.
Montevideo, December 2019. ANTEL and Bambuslife announced their strategic partnership, which brings the App-based 15-lead ECG CardioSecur to Uruguay and 20 more countries. Both companies were enthusiastic about making the clinically unrivalled ECG technology CardioSecur available in Latin America. Andrés Tolosa, president of ANTEL said: "This is a very user-friendly device which offers swift and affordable help", while Jorge Henón, founder of Bambuslife went on record: "With this device you can reach remote places where there may not be a medical specialist, but a paramedic or a nurse who can act swiftly."
CardioSecur is a cutting-edge App-based 15-lead ECG system which allows to record a uniquely detailed ECG within seconds. The entire system consists of a 50g light device with only four electrodes, the App and the user's smartphone or tablet. CardioSecur is already used in remote settings where sophisticated App-based ECG technology is usually not available - such as commercial aviation where CardioSecur is used as on-board infarction detection by prime carriers like Lufthansa.
CardioSecur is known for its unique use of an initially recorded personal reference ECG, taking account of the user's heart history. This individual "fingerprint of the heart" allows for a more accurate evaluation of any subsequent control ECG readings. Such serial ECG-recordings are explicitly required by both the European Society of Cardiology (ESC) and the American Heart Association (AHA). CardioSecur is worldwide the only ECG system complying fully with these guidelines and offers with 15-lead ECG output more information than is conventionally available in clinics. In addition, after every new control reading, the ECG provides a simple recommendation on whether to see a doctor or not.
Additional information at www.cardiosecur.com
Personal MedSystems GmbH develops and sells fully approved medical ECG systems and services for private users, healthcare professionals and aviation corporates under the name CardioSecur.
CardioSecur Active is a cutting edge, clinical-grade 15-lead ECG for personal use. Within a few seconds, it generates personalized feedback regarding changes in the heart's health. CardioSecur initially records a personal reference ECG to integrate the user's heart history. This individual "fingerprint of the heart" allows a more accurate evaluation of the current control reading. The simple recommendation to act indicates whether to see a doctor or not. A reading can be taken anytime and anywhere and does not require an internet connection. The entire system consists of a 50g light cable with four electrodes, the complimentary app and the user's smartphone or tablet.
CardioSecur Pro is the ECG solution for physicians, medical professionals and the aviation sector. CardioSecur Pro is worldwide the first clinical ECG system fully meeting the guidelines of the European Society of Cardiology by providing a 22 lead ECG that operates a 360° evaluation of the heart. It is the only system that thereby identifies infarctions on any wall of the heart and is capable of capturing and localizing even the most complex arrhythmias. ECG sophistication has never before gone any further.
Press contact: Personal MedSystems GmbH Eduard Lerperger Phone +49 (0) 151-19120692 email@example.com